Next Generation Resolution of Antiviral Gene Networks
抗病毒基因网络的下一代解决方案
基本信息
- 批准号:10461962
- 负责人:
- 金额:$ 66.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-22 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntiviral AgentsBiological AssayCOVID-19 outbreakCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsCollectionCommunicable DiseasesCommunicationComplexCytometryDNA VirusesDataEpithelial CellsFeedbackFibroblastsGene Expression ProfileGenesGrowthHerpesvirus 1Host DefenseHumanISG15 geneImmuneIndividualInfectionInfluenza A virusInheritedInterferon Type IInterferonsJAK1 geneJournalsLaboratoriesLaboratory StudyMediatingMediator of activation proteinMemoryNaturePathogenicityPeripheral Blood Mononuclear CellPhenotypePhysiologicalPredispositionProteinsRNA VirusesRefractoryRegulationResistanceResolutionSamplingSecondary toSignal TransductionSyndromeSystemTechniquesTechnologyTestingTherapeuticTimeToxic effectVaccinationVesicular stomatitis Indiana virusViralVirusVirus DiseasesWorkYellow FeverZika Virusairway epitheliumantiviral drug developmentantiviral immunitycell typecombinatorialexperimental studygene functiongene networkhigh dimensionalityhuman modelimprintin vitro Modelin vivonew technologynext generationnovelpandemic diseasepathogenic virusprogramsrespiratory pathogenresponseside effectsingle-cell RNA sequencing
项目摘要
SUMMARY
As the primary mediators of the innate response to viral infection, type I interferons (IFN-I) establish an antiviral
state in both infected and uninfected bystander cells through the induction of several hundreds of interferon
stimulated genes (ISGs). The mechanisms by which the coordinated activities of these ISGs confer resistance
to diverse viruses, and the regulatory circuits that modulate their expression remain poorly understood. Working
with unique samples from individuals with hereditary syndromes of dysregulated IFN-I responsiveness, we have
identified a collection of thirty ISGs that confer resistance to diverse viruses (increased protection against RNA
and DNA viruses with both high and low pathogenic burden). We have also uncovered previously unappreciated
negative feedback mechanisms of IFN-I signaling. We have found that these regulatory circuits, as well as ISG
expression patterns, vary significantly across different cell types at steady state and upon IFN-I stimulation.
Recent technological advances now enable us to explore these cooperative ISG antiviral functions and negative
feedback mechanisms at unprecedented depth and resolution.
In the studies proposed here, we will identify subsets of ISGs sufficient to confer broad protection against multiple
viruses using a novel single cell RNA-Seq strategy. This approach provides the throughput required to conduct
complex combinatorial experiments while maintaining the high resolution to test specific hypotheses. Results
may offer new broad spectrum antiviral therapeutic strategies, which would be of particular value against
emerging viral pathogens. We will also investigate in detail the mechanisms by which IFN-I signaling establishes
a lasting imprint on cellular responsiveness to subsequent IFN-I stimulation. This recently described but
incompletely characterized phenomenon likely has important implications for successive infectious challenges
and viral susceptibilities. Combining a unique collection of clinical samples, cutting edge technologies, and
diverse and complementary expertise in immunovirology from our two laboratories, these studies are expected
to address long standing, fundamental questions in innate antiviral immunity, as well as to pioneer new directions
for developing antiviral therapies.
总结
作为对病毒感染的先天性应答的主要介质,I型干扰素(IFN-I)建立了抗病毒的免疫调节系统。
通过诱导数百种干扰素,
刺激基因(ISG)。这些ISG的协调活动赋予抗性的机制
不同的病毒,以及调节其表达的调控电路仍然知之甚少。工作
通过从IFN-I反应性失调的遗传综合征患者中提取的独特样本,我们
鉴定了30个ISG的集合,这些ISG赋予对不同病毒的抗性(增加对RNA的保护
和具有高和低致病性负荷的DNA病毒)。我们还发现了以前未被重视的
IFN-I信号传导的负反馈机制。我们发现,这些调节电路,以及ISG
表达模式在稳态和IFN-1刺激后在不同细胞类型中显著变化。
最近的技术进步现在使我们能够探索这些合作ISG抗病毒功能和负作用。
以前所未有的深度和分辨率提供反馈机制。
在这里提出的研究中,我们将确定足以提供广泛保护的ISG子集,
病毒使用一种新的单细胞RNA-Seq策略。此方法提供了进行以下操作所需的吞吐量
复杂的组合实验,同时保持高分辨率,以测试特定的假设。结果
可能提供新的广谱抗病毒治疗策略,
新出现的病毒病原体。我们还将详细研究IFN-I信号建立的机制,
对随后的IFN-I刺激的细胞反应性的持久印记。这是最近描述的,但
不完全表征的现象可能对连续的感染性挑战具有重要意义
和病毒感染性。结合独特的临床样本收集,尖端技术,
我们的两个实验室在免疫病毒学方面具有多样和互补的专业知识,预计这些研究
解决先天性抗病毒免疫中长期存在的基本问题,并开拓新的方向
用于开发抗病毒疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dusan Bogunovic其他文献
Dusan Bogunovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dusan Bogunovic', 18)}}的其他基金
New York Regional Inborn Errors of Immunity Resource Initiative League (NY-ROYAL)
纽约地区先天性缺陷免疫资源倡议联盟 (NY-ROYAL)
- 批准号:
10554965 - 财政年份:2023
- 资助金额:
$ 66.2万 - 项目类别:
Transient Gene Therapy as Broad Spectrum Antiviral
瞬时基因疗法作为广谱抗病毒药物
- 批准号:
10324302 - 财政年份:2021
- 资助金额:
$ 66.2万 - 项目类别:
Role of SARS-CoV-2-mediated Type I IFN antagonism in individuals with Down Syndrome
SARS-CoV-2 介导的 I 型 IFN 拮抗作用在唐氏综合症患者中的作用
- 批准号:
10158984 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Inborn Errors of Immunity Leading to Autoinflammatory Syndromes
先天性免疫缺陷导致自身炎症综合征
- 批准号:
10206016 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Next Generation Resolution of Antiviral Gene Networks
抗病毒基因网络的下一代解决方案
- 批准号:
10120982 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Inborn Errors of Immunity Leading to Autoinflammatory Syndromes
先天性免疫缺陷导致自身炎症综合征
- 批准号:
10058607 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Inborn Errors of Immunity Leading to Autoinflammatory Syndromes
先天性免疫缺陷导致自身炎症综合征
- 批准号:
10443794 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Inborn Errors of Immunity Leading to Autoinflammatory Syndromes
先天性免疫缺陷导致自身炎症综合征
- 批准号:
10655435 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Next Generation Resolution of Antiviral Gene Networks
抗病毒基因网络的下一代解决方案
- 批准号:
10681411 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 66.2万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 66.2万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 66.2万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 66.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 66.2万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 66.2万 - 项目类别:














{{item.name}}会员




